APA (7th ed.) Citation

S, S., K, C., Y, K., S, T., E, O., E, U., . . . F, S. (2023). Efficacy of plasma atherogenic index in predicting malignancy in the presence of Prostate Imaging-Reporting and Data System 3 (PI-RADS 3) prostate lesions. International urology and nephrology, 55(2), 255. https://doi.org/10.1007/s11255-022-03409-9

Chicago Style (17th ed.) Citation

S, Senel, Ceviz K, Kasap Y, Tastemur S, Olcucuoglu E, Uzun E, Polat ME, Koudonas A, and Sarialtin F. "Efficacy of Plasma Atherogenic Index in Predicting Malignancy in the Presence of Prostate Imaging-Reporting and Data System 3 (PI-RADS 3) Prostate Lesions." International Urology and Nephrology 55, no. 2 (2023): 255. https://doi.org/10.1007/s11255-022-03409-9.

MLA (9th ed.) Citation

S, Senel, et al. "Efficacy of Plasma Atherogenic Index in Predicting Malignancy in the Presence of Prostate Imaging-Reporting and Data System 3 (PI-RADS 3) Prostate Lesions." International Urology and Nephrology, vol. 55, no. 2, 2023, p. 255, https://doi.org/10.1007/s11255-022-03409-9.